Abstract
Autism spectrum disorder (ASD) is a complex disease with onset during early childhood and typically a lifelong course. Genetic liability plays a prominent role in ASD, as siblings of affected individuals display on average 25-fold higher autism risk rates compared to the general population. However, genetic contributions fit in most cases with complex, “multiple-hit,” oligogenic/polygenic models encompassing several loci and also gene-environment interactions. Furthermore, ASD should be viewed as the extreme end of a set of continuous dimensions pertaining to the realms of human socialization, language development, and behavior, rather than as a “black or white” medical condition. This complexity spurs interest into the heuristic potential of “endophenotypes” in ASD, as originally applied by Gottesman and Shields (Br J Psychiatry 122:15–30, 1973) to the realm of psychiatry. Endophenotypes can be defined as familial, heritable, and quantitative traits associated with a complex disease. Occupying an intermediate position between genotype and behavior, these traits offer the potential to bridge the gap between complex disease phenotypes, such as autism, and the underlying genetic mechanisms. The most reliable endophenotypes in ASD can be grouped into seven categories: biochemical, morphological, hormonal, immunological, neurophysiological/neuroanatomical, neuropsychological, and behavioral. Their use holds promise to foster advances not only toward more reliable genotype-phenotype correlations in autism research but also in dissecting clinical subgroups of ASD patients with relatively homogeneous pathophysiological underpinnings, aiding clinicians in early diagnosis once incorporated into broader biomarker panels, and predicting developmental trajectories and treatment response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adolphs R, Spezio ML, Parlier M, et al. Distinct face-processing strategies in parents of autistic children. Curr Biol. 2008;18:1090–3.
Alarcón M, Abrahamas BS, Stone JL, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet. 2008;82:150–9.
Altieri L, Neri C, Sacco R, et al. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers. 2011;16:252–60.
Anderson GM, Horne WC, Chatterjee D, et al. The hyperserotonemia of autism. Ann N Y Acad Sci. 1990;600:331–40.
Ashwood P, Wills S, Van de Water J, et al. The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006;80:1–15. [Epub 2006 May 12].
Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25:63–77.
Baron-Cohen S, Scott FJ, Allison C, et al. Prevalence of autism − spectrum conditions: UK school − based population study. Br J Psychiatry. 2009;194:500–9.
Belmonte MK, Gomot M, Baron-Cohen S. Visual attention in autism families: ‘unaffected’ sibs share atypical frontal activation. J Child Psychol Psychiatry. 2010;51:259–76.
Bradford Y, Haines J, Hutcheson H, et al. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet. 2001;105:539–47.
Bruneau N, Bonnet-Brilhault F, Gomot M, et al. Cortical auditory processing and communication in children with autism: electrophysiological/behavioral relations. Int J Psychophysiol. 2003;51:17–25.
Cass H, Gringras P, March J, et al. Absence of urinary opioid peptides in children with autism. Arch Dis Child. 2008;93:745–50.
Cook Jr EH, Leventhal BL, Freedman DX. Free serotonin in plasma: autistic children and their first-degree relatives. Biol Psychiatry. 1988;24:488–91.
Cortesi F, Giannotti F, Sebastiani T, et al. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial. J Sleep Res. 2012;21:700. [Epub ahead of print].
Courchesne E, Pierce K, Schumann CM, et al. Mapping early brain development in autism. Neuron. 2007;56:399–413.
Crino PB. mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med. 2011;17:734–42.
Croen LA, Braunschweig D, Haapanen L, et al. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry. 2008;64:583–8.
Dapretto M, Davies MS, Pfeifer JH, et al. Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders. Nat Neurosci. 2006;9:28–30.
Delorme R, Goussé V, Roy I, et al. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder. Eur Psychiatry. 2007;22:32–8.
Dettmer K, Hanna D, Whetstone P, et al. Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal Bioanal Chem. 2007;388:1643–51.
Ecker C, Marquand A, Mourão-Miranda J, et al. Describing the brain in autism in five dimensions–magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. J Neurosci. 2010;30:10612–23.
Ecker C, Suckling J, Deoni SC, et al. Brain anatomy and its relationship to behavior in adults with autism spectrum disorder: a multicenter magnetic resonance imaging study. Arch Gen Psychiatry. 2012;69:195–209.
Feldman R. Oxytocin and social affiliation in humans. Horm Behav. 2012;61:380–91.
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591–8.
Goines P, Haapanen L, Boyce R, et al. Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun. 2011;25:514–23.
Gomot M, Belmonte MK, Bullmore ET, et al. Brain hyper-reactivity to auditory novel targets in children with high-functioning autism. Brain. 2008;131:2479–88.
Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003;160:636–45.
Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry. 1973;122:15–30.
Grether JK, Rosen NJ, Smith KS, et al. Investigation of shifts in autism reporting in the California Department of Developmental Services. J Autism Dev Disord. 2009;39:1412–9.
Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68:1095–102.
Hammock E, Veenstra-Vanderweele J, Yan Z, et al. Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J Am Acad Child Adolesc Psychiatry. 2012;51:712–21.
Hammond P, Forster-Gibson C, Chudley AE, et al. Face-brain asymmetry in autism spectrum disorders. Mol Psychiatry. 2008;13:614–23.
Hertz-Picciotto I, Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology. 2009;20:84–90.
Hollander E, Bartz J, Chaplin W, et al. Oxytocin increases retention of social cognition in autism. Biol Psychiatry. 2007;61:498–503.
Hunter LC, O’Hare A, Herron WJ, et al. Opioid peptides and dipeptidyl peptidase in autism. Dev Med Child Neurol. 2003;45:121–8.
John B, Lewis KR. Chromosome variability and geographic distribution in insects. Science. 1966;152:711–21.
Kaiser MD, Hudac CM, Shultz S, et al. Neural signatures of autism. Proc Natl Acad Sci U S A. 2010;107:21223–8.
Katsui T, Okuda M, Usuda S, et al. Kinetics of3 H-serotonin uptake by platelets in infantile autism and developmental language disorder (including five pairs of twins). J Autism Dev Disord. 1986;16:69–76.
King M, Bearman P. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 2009;38:1224–34.
Lesch KP, Wolozin BL, Murphy DL, et al. Primary structure of the human platelet serotonin (5-HT) uptake site: identity with the brain 5-HT transporter. J Neurochem. 1993;60:2319–22.
Liu XQ, Paterson AD, Szatmari P, et al. Genome-wide linkage analyses of quantitative and categorical autism subphenotypes. Biol Psychiatry. 2008;64:561–70.
Lucht MJ, Barnow S, Sonnenfeld C, et al. Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Aug 1;33:860–866.
Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009;10:307–18.
Marazziti D, Muratori F, Cesari A, et al. Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry. 2000;33:165–8.
McBride PA, Anderson GM, Hertzig ME, et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry. 1998;37:767–76.
Melke J, Goubran Botros H, Chaste P, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13:90–8.
Miles JH, Hadden LL, Takahashi TN, et al. Head circumference is an independent clinical finding associated with autism. Am J Med Genet. 2000;95:339–50.
Modahl C, Green L, Fein D, et al. Plasma oxytocin levels in autistic children. Biol Psychiatry. 1998;43:270–7.
Persico AM. Autisms. In: Rakic P, Rubenstein J, editors. Comprehensive developmental neuroscience. San Diego: Elsevier; 2012.
Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006;29:349–58.
Piven J, Tsai GC, Nehme E, et al. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord. 1991;21:51–9.
Piven J, Palmer P, Jacobi D, et al. Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry. 1997;154:185–90.
Reichelt WH, Knivsberg AM, Nodland M, et al. Urinary peptide levels and patterns in autistic children from seven countries, and the effect of dietary intervention after 4 years. Dev Brain Dysfunct. 1997;10:44–55.
Rossi CC, Van de Water J, Rogers SJ, et al. Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain Behav Immun. 2011;25:1123–35.
Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53:783–92.
Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr. 2005;94:2–15.
Sacco R, Militerni R, Frolli A, et al. Clinical, morphological, and biochemical correlates of head circumference in autism. Biol Psychiatry. 2007;62:1038–47.
Sacco R, Curatolo P, Manzi B, et al. Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res. 2010;3:237–52.
Sacco R, Lenti C, Saccani M, et al. Cluster analysis of autistic patients based on principal pathogenetic components. Autism Res. 2012;5:137–47.
Saresella M, Marventano I, Guerini FR, et al. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry. 2009;66:978–84.
Spence SJ, Cantor RM, Chung L, et al. Stratification based on language-related endophenotypes in autism: attempt to replicate reported linkage. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:591–8.
Spezio ML, Adolphs R, Hurley RS, et al. Abnormal use of facial information in high-functioning autism. J Autism Dev Disord. 2007;37:929–39.
Steffenburg S, Gillberg C, Hellgren L, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry. 1989;30:405–16.
Tordjman S, Anderson GM, Bellissant E, et al. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology. 2012;37(12):1990. [Epub ahead of print].
Tripi G, Roux S, Canziani T, et al. Minor physical anomalies in children with autism spectrum disorder. Early Hum Dev. 2008;84:217–23.
Tropea D, Giacometti E, Wilson NR, et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A. 2009;106:2029–34.
Veenstra-VanderWeele J, Blakely RD. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology. 2012;37:196–212.
Wallace GL, Happé F, Giedd JN. A case study of a multiply talented savant with an autism spectrum disorder: neuropsychological functioning and brain morphometry. Philos Trans R Soc Lond B Biol Sci. 2009;364:1425–32.
Walsh P, Elsabbagh M, Bolton P, et al. In search of biomarkers for autism: scientific, social and ethical challenges. Nat Rev Neurosci. 2011;12:603–12.
Walum H, Lichtenstein P, Neiderhiser JM, et al. Variation in the oxytocin receptor gene is associated with pair-bonding and social behavior. Biol Psychiatry. 2012;71:419–26.
Wang L, Angley MT, Gerber JP, et al. A review of candidate urinary biomarkers for autism spectrum disorder. Biomarkers. 2011;16:537–52.
Weisman O, Zagoory-Sharon O, Feldman R. Oxytocin administration to parent enhances infant physiological and behavioral readiness for social engagement. Biol Psychiatry. 2012;72:982. [Epub ahead of print].
Wills S, Rossi CC, Bennett J, et al. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Mol Autism. 2011;2:5.
Yap IK, Angley M, Veselkov KA, et al. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res. 2010;9:2996–3004.
Young LJ, Wang Z, Insel TR. Neuroendocrine bases of monogamy. Trends Neurosci. 1998;21:71–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Persico, A.M., Sacco, R. (2014). Endophenotypes in Autism Spectrum Disorders. In: Patel, V., Preedy, V., Martin, C. (eds) Comprehensive Guide to Autism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4788-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4788-7_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4787-0
Online ISBN: 978-1-4614-4788-7
eBook Packages: Behavioral Science